Coexisting Polymorphisms of P2Y12 and CYP2C19 Genes as a Risk Factor for Persistent Platelet Activation With Clopidogrel
- 1 January 2008
- journal article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 72 (7) , 1165-1169
Abstract
Background Coexisting polymorphisms of the genes affecting clopiogrel resistance may influence platelet activation. Methods and Results In 105 patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention, platelet function was measured and registered as closure time in the test with collagen and adenosine diphosphate (CADP-CT). Patients were followed for 12 months for death or recurrent myocardial infarction (MI). Genotyping revealed 7 carriers of both the C allele of P2Y12 and A allele of CYP2C19 (group 1), 14 carriers of the T allele of P2Y12 and A allele of CYP2C19 (group 2), 17 carriers of the C allele of P2Y12 and G allele of CYP2C19 (group 3) and 67 carriers of the T allele of P2Y12 and G allele of CYP2C19 (controls). The median CADP-CT value was significantly lower in group 1 than in group 2 or 3 (pCirc J 2008; 72: 1165 - 1169)Keywords
This publication has 28 references indexed in Scilit:
- Variability in Individual Responsiveness to ClopidogrelJACC, 2007
- Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrelThrombosis Research, 2007
- Impact of P-glycoprotein on clopidogrel absorptionClinical Pharmacology & Therapeutics, 2006
- Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsBlood, 2006
- Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to ClopidogrelArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrelCanadian Medical Association Journal, 2006
- Aspirin and clopidogrel resistance: an emerging clinical entityEuropean Heart Journal, 2005
- P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading doseBlood Coagulation & Fibrinolysis, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJACC, 2005
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001